NeuroscienceBiomedicine & PharmacotherapyPeer-reviewed
Drug repurposing of dopaminergic drugs to inhibit Ataxin-3 aggregation
Francisco Figueiredo, Zsuzsa Sárkány, Alexandra Silva…·Sandra Macedo‐Ribeiro
This study identifies dopamine and catecholamines as inhibitors of Atx3 aggregation, suggesting potential use of dopaminergic drugs for MJD treatment.